Anti-GGCX monoclonal antibody

Pre-made anti-GGCX monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to GGCX/GGCX products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP0024-Ab-1/ GM-Tg-hg-IP0024-Ab-2Anti-Human GGCX monoclonal antibodyHuman
GM-Tg-rg-IP0024-Ab-1/ GM-Tg-rg-IP0024-Ab-2Anti-Rat GGCX monoclonal antibodyRat
GM-Tg-mg-IP0024-Ab-1/ GM-Tg-mg-IP0024-Ab-2Anti-Mouse GGCX monoclonal antibodyMouse
GM-Tg-cynog-IP0024-Ab-1/ GM-Tg-cynog-IP0024-Ab-2Anti-Cynomolgus/ Rhesus macaque GGCX monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP0024-Ab-1/ GM-Tg-felg-IP0024-Ab-2Anti-Feline GGCX monoclonal antibodyFeline
GM-Tg-cang-IP0024-Ab-1/ GM-Tg-cang-IP0024-Ab-2Anti-Canine GGCX monoclonal antibodyCanine
GM-Tg-bovg-IP0024-Ab-1/ GM-Tg-bovg-IP0024-Ab-2Anti-Bovine GGCX monoclonal antibodyBovine
GM-Tg-equg-IP0024-Ab-1/ GM-Tg-equg-IP0024-Ab-2Anti-Equine GGCX monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP0024-Ab-1/ GM-Tg-hg-IP0024-Ab-2; GM-Tg-rg-IP0024-Ab-1/ GM-Tg-rg-IP0024-Ab-2;
GM-Tg-mg-IP0024-Ab-1/ GM-Tg-mg-IP0024-Ab-2; GM-Tg-cynog-IP0024-Ab-1/ GM-Tg-cynog-IP0024-Ab-2;
GM-Tg-felg-IP0024-Ab-1/ GM-Tg-felg-IP0024-Ab-2; GM-Tg-cang-IP0024-Ab-1/ GM-Tg-cang-IP0024-Ab-2;
GM-Tg-bovg-IP0024-Ab-1/ GM-Tg-bovg-IP0024-Ab-2; GM-Tg-equg-IP0024-Ab-1/ GM-Tg-equg-IP0024-Ab-2
Products NameAnti-GGCX monoclonal antibody
Formatmab
Target NameGGCX
Protein Sub-locationIntrocelluar Protein
Category of antibodyTherapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-GGCX monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP0024-Ag-1Recombinant multi-species VKGC/ GGCX/ VKCFD1 protein


    Target information

    Target IDGM-IP0024
    Target NameGGCX
    Gene ID2677,56316,81716,695628,475769,101085622,281190,100067312
    Gene Symbol and SynonymsGGCX,VKCFD1
    Uniprot AccessionP38435,O88496,Q07175
    Uniprot Entry NameVKGC_HUMAN,VKGC_RAT,VKGC_BOVIN
    Protein Sub-locationIntrocelluar Protein
    CategoryTherapeutics Target
    DiseaseN/A
    Gene EnsemblENSG00000115486
    Target ClassificationN/A

    The target: GGCX, gene name: GGCX, also named as VKCFD1. This gene encodes an integral membrane protein of the rough endoplasmic reticulum that carboxylates glutamate residues of vitamin K-dependent proteins to gamma carboxyl glutamate, a modification that is required for their activity. The vitamin K-dependent protein substrates have a propeptide that binds the enzyme, with carbon dioxide, dioxide, and reduced vitamin K acting as co-substrates. Vitamin K-dependent proteins affect a number of physiologic processes including blood coagulation, prevention of vascular calcification, and inflammation. Allelic variants of this gene have been associated with pseudoxanthoma elasticum-like disorder with associated multiple coagulation factor deficiency. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2015].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.